We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Histology Reveals Characteristics of Superimposed Bacterial Ulcerative Colitis

By LabMedica International staff writers
Posted on 23 Jan 2014
Biopsy specimens have been examined for histologic features suggestive of Clostridium difficile infection in patients with ulcerative colitis.

In patients with acutely symptomatic ulcerative colitis, it is important to determine whether the underlying cause of the disease is due to a C. More...
difficile infection or may arise due to other infectious organisms and or bowel ischemia.

Pathologists at St Michael’s Hospital (Toronto, ON, Canada) examined nine patients with ulcerative colitis who had colonic biopsy specimens taken during a symptomatic flare that coincided with positive C. difficile (C. difficile+) tests. They also examined 28 controls that were biopsied during an ulcerative colitis flare, but tested negative for C. difficile. The scientists reviewed the histological slides for evidence of pseudomembranes, ischemic-like changes, degree of colitis, and lamina propria hemorrhage. Pseudomembranes are not real membranes: they represent necrotic debris attached to the colonic wall and may vaguely resemble a volcanic eruption, when examined microscopically.

Stool testing was performed using the C. difficile Tox A/B II enzyme immunoassay (EIA) (Techlab; Blacksburg, VA, USA). The results were analyzed with a dual-wavelength spectrometer at 450 nm and 620 nm. In the patients who had a positive C. difficile+ test, four of nine (44.4%) had microscopic pseudomembranes compared with only 11% in controls who were C. difficile negative, which was statistically significant. The investigators found that other histologic and clinical features were not predictive.

The authors concluded that although the presence of microscopic pseudomembranes suggests C. difficile infection in patients with ulcerative colitis, sensitivity and specificity were poor; biopsy findings do not reliably detect this infection in patients with ulcerative colitis. However, the authors propose that histologic findings of microscopic pseudomembranes should also prompt testing for C. difficile if not already performed.

Ulcerative colitis is a form of inflammatory bowel disease (IBD). It is a disease of the colon that includes characteristic ulcers, or open sores. The main symptom of active disease is usually constant diarrhea mixed with blood, of gradual onset. IBD is often confused with irritable bowel syndrome. The study was published in the December 2013 issue of the American Journal of Clinical Pathology.

Related Links:

St Michael’s Hospital
Techlab



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
New
Gastrointestinal Panel
Xpert® GI Panel
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers from the Department of Chemistry at Aarhus University have developed and tested a new technology that can identify and measure the concentration of pharmaceuticals in under 10 minutes. Today, this process takes up to an hour. That is critical waiting time for patients suffering from a stroke. (Image Credit: Aarhus University)

Point-of-Care Blood Test Could Speed Treatment Decisions in Acute Stroke

Minutes can shape treatment decisions in emergency stroke care, particularly when physicians need to know whether a patient is taking anticoagulants before administering clot-dissolving therapy.... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.